ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,654
Screening encounters
1,756
Diagnostic referrals
332
Outstanding pathways
151

Screening pathway

  1. Screening1,756Encounters
  2. Positive finding584Documented findings
  3. Referral332Diagnostic referrals
  4. Follow-up361Diagnostic visits
  5. Outcome181Resolved pathways

Stage totals use different units. Pending pathways: 151. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4585 · EXP-4585Synthetic · Site D

Full participant history through 2025-10-28, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-09-19
  4. · Diagnostic referral · EXP-4585-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-18
  11. · Follow-up disposition · Resolved · EXP-4585-T-R
  12. · Screening · HPV DNA · Repeat · Prior VIA positive
  13. · Screening result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

1654 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4321 · Expanded synthetic participant 4321Site C — Rural Outreach Programme
EXP-4323 · Expanded synthetic participant 4323Site D — Community Engagement Programme
EXP-4325 · Expanded synthetic participant 4325Site B — Peri-Urban Access Programme
EXP-4326 · Expanded synthetic participant 4326Site A — Urban Referral Hub
EXP-4327 · Expanded synthetic participant 4327Site D — Community Engagement Programme
EXP-4331 · Expanded synthetic participant 4331Site E — Resource-Constrained Navigation Programme
EXP-4333 · Expanded synthetic participant 4333Site B — Peri-Urban Access Programme
EXP-4334 · Expanded synthetic participant 4334Site C — Rural Outreach Programme
EXP-4335 · Expanded synthetic participant 4335Site A — Urban Referral Hub
EXP-4338 · Expanded synthetic participant 4338Site A — Urban Referral Hub
EXP-4341 · Expanded synthetic participant 4341Site D — Community Engagement Programme
EXP-4342 · Expanded synthetic participant 4342Site A — Urban Referral Hub
EXP-4344 · Expanded synthetic participant 4344Site C — Rural Outreach Programme
EXP-4345 · Expanded synthetic participant 4345Site B — Peri-Urban Access Programme
EXP-4355 · Expanded synthetic participant 4355Site A — Urban Referral Hub
EXP-4356 · Expanded synthetic participant 4356Site A — Urban Referral Hub
EXP-4360 · Expanded synthetic participant 4360Site C — Rural Outreach Programme
EXP-4364 · Expanded synthetic participant 4364Site D — Community Engagement Programme
EXP-4373 · Expanded synthetic participant 4373Site E — Resource-Constrained Navigation Programme
EXP-4381 · Expanded synthetic participant 4381Site A — Urban Referral Hub
EXP-4383 · Expanded synthetic participant 4383Site A — Urban Referral Hub
EXP-4389 · Expanded synthetic participant 4389Site B — Peri-Urban Access Programme
EXP-4391 · Expanded synthetic participant 4391Site A — Urban Referral Hub
EXP-4393 · Expanded synthetic participant 4393Site D — Community Engagement Programme
EXP-4399 · Expanded synthetic participant 4399Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
740
HPV DNA
767
Cytology
249

Navigation activity

Barrier documented
279
Contact attempt
483
Navigation intervention
115
Diagnostic booking
404
Diagnostic visit
361

Documented barriers

Contact difficulty
87
Transport difficulty
94
Appointment coordination
98

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.